These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

379 related items for PubMed ID: 34592228

  • 1. 3-Epipachysamine B suppresses proliferation and induces apoptosis of breast cancer cell via PI3K/AKT/mTOR signaling pathway.
    Zhang L, Zheng Y, Zeng L, Zhang F, Che D, Cao Z, Huang C, Xian L, Zhang X, Zhang H, Guo Z.
    Life Sci; 2021 Nov 15; 285():119995. PubMed ID: 34592228
    [Abstract] [Full Text] [Related]

  • 2. Benzo[b]furan derivatives induces apoptosis by targeting the PI3K/Akt/mTOR signaling pathway in human breast cancer cells.
    Kamal A, Lakshma Nayak V, Nagesh N, Vishnuvardhan MV, Subba Reddy NV.
    Bioorg Chem; 2016 Jun 15; 66():124-31. PubMed ID: 27149364
    [Abstract] [Full Text] [Related]

  • 3. 6-Methoxydihydrosanguinarine induces apoptosis and autophagy in breast cancer MCF-7 cells by accumulating ROS to suppress the PI3K/AKT/mTOR signaling pathway.
    Zhang L, Zhang X, Che D, Zeng L, Zhang Y, Nan K, Zhang X, Zhang H, Guo Z.
    Phytother Res; 2023 Jan 15; 37(1):124-139. PubMed ID: 36116140
    [Abstract] [Full Text] [Related]

  • 4. Silybin suppresses cell proliferation and induces apoptosis of multiple myeloma cells via the PI3K/Akt/mTOR signaling pathway.
    Feng N, Luo J, Guo X.
    Mol Med Rep; 2016 Apr 15; 13(4):3243-8. PubMed ID: 26936429
    [Abstract] [Full Text] [Related]

  • 5. Dual inhibition of PI3K and mTOR mitigates compensatory AKT activation and improves tamoxifen response in breast cancer.
    Chen X, Zhao M, Hao M, Sun X, Wang J, Mao Y, Zu L, Liu J, Shen Y, Wang J, Shen K.
    Mol Cancer Res; 2013 Oct 15; 11(10):1269-78. PubMed ID: 23814023
    [Abstract] [Full Text] [Related]

  • 6. LY294002 and metformin cooperatively enhance the inhibition of growth and the induction of apoptosis of ovarian cancer cells.
    Li C, Liu VW, Chan DW, Yao KM, Ngan HY.
    Int J Gynecol Cancer; 2012 Jan 15; 22(1):15-22. PubMed ID: 22080879
    [Abstract] [Full Text] [Related]

  • 7. LY294002 and Rapamycin promote coxsackievirus-induced cytopathic effect and apoptosis via inhibition of PI3K/AKT/mTOR signaling pathway.
    Chen Z, Yang L, Liu Y, Tang A, Li X, Zhang J, Yang Z.
    Mol Cell Biochem; 2014 Jan 15; 385(1-2):169-77. PubMed ID: 24072614
    [Abstract] [Full Text] [Related]

  • 8. Regulation of the cell cycle and PI3K/Akt/mTOR signaling pathway by tanshinone I in human breast cancer cell lines.
    Wang L, Wu J, Lu J, Ma R, Sun D, Tang J.
    Mol Med Rep; 2015 Feb 15; 11(2):931-9. PubMed ID: 25355053
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of Prostate Cancer DU-145 Cells Proliferation by Anthopleura anjunae Oligopeptide (YVPGP) via PI3K/AKT/mTOR Signaling Pathway.
    Li X, Tang Y, Yu F, Sun Y, Huang F, Chen Y, Yang Z, Ding G.
    Mar Drugs; 2018 Sep 11; 16(9):. PubMed ID: 30208576
    [Abstract] [Full Text] [Related]

  • 10. Single Agent and Synergistic Activity of the "First-in-Class" Dual PI3K/BRD4 Inhibitor SF1126 with Sorafenib in Hepatocellular Carcinoma.
    Singh AR, Joshi S, Burgoyne AM, Sicklick JK, Ikeda S, Kono Y, Garlich JR, Morales GA, Durden DL.
    Mol Cancer Ther; 2016 Nov 11; 15(11):2553-2562. PubMed ID: 27496136
    [Abstract] [Full Text] [Related]

  • 11. LY‑294002 enhances the chemosensitivity of liver cancer to oxaliplatin by blocking the PI3K/AKT/HIF‑1α pathway.
    Xu R, Zhang Y, Li A, Ma Y, Cai W, Song L, Xie Y, Zhou S, Cao W, Tang X.
    Mol Med Rep; 2021 Jul 11; 24(1):. PubMed ID: 33982772
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of Autophagy Increases Proliferation Inhibition and Apoptosis Induced by the PI3K/mTOR Inhibitor NVP-BEZ235 in Breast Cancer Cells.
    Ji Y, Di W, Yang Q, Lu Z, Cai W, Wu J.
    Clin Lab; 2015 Jul 11; 61(8):1043-51. PubMed ID: 26427150
    [Abstract] [Full Text] [Related]

  • 13. AMR-Me inhibits PI3K/Akt signaling in hormone-dependent MCF-7 breast cancer cells and inactivates NF-κB in hormone-independent MDA-MB-231 cells.
    Rabi T, Huwiler A, Zangemeister-Wittke U.
    Mol Carcinog; 2014 Jul 11; 53(7):578-88. PubMed ID: 23475563
    [Abstract] [Full Text] [Related]

  • 14. Probing the PI3K/Akt/mTor pathway using 31P-NMR spectroscopy: routes to glycogen synthase kinase 3.
    Phyu SM, Tseng CC, Fleming IN, Smith TA.
    Sci Rep; 2016 Nov 04; 6():36544. PubMed ID: 27811956
    [Abstract] [Full Text] [Related]

  • 15. Gigantol inhibits proliferation and enhances DDP-induced apoptosis in breast-cancer cells by downregulating the PI3K/Akt/mTOR signaling pathway.
    Huang J, Liu C, Duan S, Lin J, Luo Y, Tao S, Xing S, Zhang X, Du H, Wang H, Huang C, Wei G.
    Life Sci; 2021 Jun 01; 274():119354. PubMed ID: 33737087
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of constitutively activated phosphoinositide 3-kinase/AKT pathway enhances antitumor activity of chemotherapeutic agents in breast cancer susceptibility gene 1-defective breast cancer cells.
    Yi YW, Kang HJ, Kim HJ, Hwang JS, Wang A, Bae I.
    Mol Carcinog; 2013 Sep 01; 52(9):667-75. PubMed ID: 22488590
    [Abstract] [Full Text] [Related]

  • 17. Network Pharmacology and Experimental Evidence Reveal Dioscin Suppresses Proliferation, Invasion, and EMT via AKT/GSK3b/mTOR Signaling in Lung Adenocarcinoma.
    Mao W, Yin H, Chen W, Zhao T, Wu S, Jin H, Du B, Tan Y, Zhang R, He Y.
    Drug Des Devel Ther; 2020 Sep 01; 14():2135-2147. PubMed ID: 32546976
    [Abstract] [Full Text] [Related]

  • 18. Baicalein induces apoptosis and autophagy of breast cancer cells via inhibiting PI3K/AKT pathway in vivo and vitro.
    Yan W, Ma X, Zhao X, Zhang S.
    Drug Des Devel Ther; 2018 Sep 01; 12():3961-3972. PubMed ID: 30510404
    [Abstract] [Full Text] [Related]

  • 19. Epidermal growth factor induces HCCR expression via PI3K/Akt/mTOR signaling in PANC-1 pancreatic cancer cells.
    Xu Z, Zhang Y, Jiang J, Yang Y, Shi R, Hao B, Zhang Z, Huang Z, Kim JW, Zhang G.
    BMC Cancer; 2010 Apr 27; 10():161. PubMed ID: 20423485
    [Abstract] [Full Text] [Related]

  • 20. A study on regulatory mechanism of miR-223 in ulcerative colitis through PI3K/Akt-mTOR signaling pathway.
    Jiang W, Han YP, Hu M, Bao XQ, Yan Y, Chen G.
    Eur Rev Med Pharmacol Sci; 2019 Jun 27; 23(11):4865-4872. PubMed ID: 31210320
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.